Ozempic is a weekly GLP-1 injection for diabetes. Phentermine is a daily pill and controlled substance for short-term weight loss. They work through entirely different mechanisms. For weight loss, the appropriate GLP-1 comparison is phentermine vs. Wegovy since Ozempic isn't FDA-approved for weight management.
The key difference: timeline and mechanism
Ozempic (semaglutide) is a GLP-1 receptor agonist that mimics gut hormones to reduce hunger, slow digestion, and improve metabolic health. It's a long-term, chronic medication. Its FDA-approved weight loss version is Wegovy.
Phentermine is a sympathomimetic amine — essentially, it stimulates the central nervous system similar to amphetamines. It suppresses appetite through norepinephrine release. It's FDA-approved only for short-term use (typically 12 weeks) and is a Schedule IV controlled substance.
GLP-1 medications are designed for long-term weight management. Phentermine is designed for short-term kickstarts. They solve different problems on different timelines.
Side-by-side comparison
| Feature | Ozempic | Phentermine |
|---|---|---|
| Active ingredient | Semaglutide | Phentermine HCl |
| Drug class | GLP-1 receptor agonist | Sympathomimetic amine |
| FDA indication | Type 2 diabetes | Short-term weight loss |
| Administration | Weekly injection | Daily oral tablet |
| Duration of use | Chronic (long-term) | Short-term (typically 12 weeks) |
| Avg weight loss | ~10–12% (off-label) | ~5–7% body weight |
| Controlled substance | No | Yes (Schedule IV) |
| Common side effects | Nausea, diarrhea, constipation | Dry mouth, insomnia, elevated heart rate |
| CV considerations | MACE benefit (via Wegovy) | Can increase heart rate and blood pressure |
| Cost without insurance | ~–,300/mo | ~–75/mo (generic) |
| Weight regain after stopping | Common without plan | Very common (designed as temporary) |
When phentermine may fit
- You need short-term appetite suppression to jumpstart weight loss
- Budget is a major factor (phentermine is the least expensive weight loss medication)
- Your insurance requires step therapy before approving a GLP-1
- You prefer an oral medication over injections
- You have no history of cardiovascular disease, uncontrolled hypertension, or stimulant sensitivity
When a GLP-1 fits better
- You need a long-term weight management solution, not a temporary boost
- Maximum weight loss is the priority
- You have cardiovascular risk factors
- You want metabolic benefits beyond appetite suppression
- Your insurance covers GLP-1 medications for weight management
Phentermine and GLP-1 medications are sometimes used together under careful supervision. Phentermine can provide initial momentum while a GLP-1 is being titrated up. Some patients also use phentermine as a bridge during GLP-1 supply disruptions or insurance authorization delays. At PEAK, our clinicians manage these combinations when clinically appropriate.
Short-term vs. long-term: when each makes sense
Phentermine has been FDA-approved since 1959 and remains one of the most commonly prescribed weight loss medications in the United States. It works as a sympathomimetic amine — essentially a stimulant that suppresses appetite. It is effective for short-term use (typically 12 weeks), but it is a Schedule IV controlled substance and is not intended for long-term treatment.
If your goal is sustained weight loss over months or years, the clinical evidence favors GLP-1 medications like Wegovy (the weight-loss formulation of semaglutide, the same active ingredient in Ozempic). In the STEP 1 trial, patients on semaglutide 2.4 mg lost approximately 15% of body weight over 68 weeks. Phentermine does not have comparable long-term trial data because it was never studied beyond short-term use.
At PEAK, we sometimes prescribe phentermine as a bridge — for example, while a GLP-1 prior authorization is pending or during the early titration weeks before a GLP-1 reaches its effective dose. This gives patients an immediate tool while the longer-term medication ramps up.
Our clinical perspective
PEAK prescribes both phentermine and GLP-1 medications (Wegovy, Zepbound). We do not prescribe Ozempic for weight loss since FDA-approved weight loss alternatives exist.
Phentermine remains a valuable tool in weight management. It's affordable, effective for short-term use, and can work synergistically with other treatments. For patients seeking long-term management, GLP-1 medications offer more sustained results and metabolic benefits.
Your clinician will recommend the right tool — or combination of tools — based on your specific situation. Schedule a consultation to discuss your options.
Boxed warning — thyroid C-cell tumors: GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Tell your provider immediately if you notice a lump in your neck, difficulty swallowing, or persistent hoarseness.
